Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michael Ellison is active.

Publication


Featured researches published by Michael Ellison.


Proceedings of the National Academy of Sciences of the United States of America | 2006

Molecular mechanism for analgesia involving specific antagonism of α9α10 nicotinic acetylcholine receptors

Michelle Vincler; Shannon Wittenauer; Renee Parker; Michael Ellison; Baldomero M. Olivera; J. Michael McIntosh

α9α10 nicotinic acetylcholine receptors (nAChRs) have been identified in a variety of tissues including lymphocytes and dorsal root ganglia; except in the case of the auditory system, the function of α9α10 nAChRs is not known. Here we show that selective block (rather than stimulation) of α9α10 nAChRs is analgesic in an animal model of nerve injury pain. In addition, blockade of this nAChR subtype reduces the number of choline acetyltransferase-positive cells, macrophages, and lymphocytes at the site of injury. Chronic neuropathic pain is estimated to affect up to 8% of the worlds population; the numerous analgesic compounds currently available are largely ineffective and act through a small number of pharmacological mechanisms. Our findings not only suggest a molecular mechanism for the treatment of neuropathic pain but also demonstrate the involvement of α9α10 nAChRs in the pathophysiology of peripheral nerve injury.


Journal of Molecular Biology | 2008

α-RgIA, a Novel Conotoxin That Blocks the α9α10 nAChR: Structure and Identification of Key Receptor-Binding Residues

Michael Ellison; Zhi Ping Feng; Anthony J. Park; Xuecheng Zhang; Baldomero M. Olivera; J. Michael McIntosh; Raymond S. Norton

Alpha-conotoxins are small disulfide-constrained peptides from cone snails that act as antagonists at specific subtypes of nicotinic acetylcholine receptors (nAChRs). The 13-residue peptide alpha-conotoxin RgIA (alpha-RgIA) is a member of the alpha-4,3 family of alpha-conotoxins and selectively blocks the alpha9alpha10 nAChR subtype, in contrast to another well-characterized member of this family, alpha-conotoxin ImI (alpha-ImI), which is a potent inhibitor of the alpha7 and alpha3beta2 nAChR subtypes. In this study, we have altered side chains in both the four-residue and the three-residue loops of alpha-RgIA, and have modified its C-terminus. The effects of these changes on activity against alpha9alpha10 and alpha7 nAChRs were measured; the solution structures of alpha-RgIA and its Y10W, D5E, and P6V analogues were determined from NMR data; and resonance assignments were made for alpha-RgIA [R9A]. The structures for alpha-RgIA and its three analogues were well defined, except at the chain termini. Comparison of these structures with reported structures of alpha-ImI reveals a common two-loop backbone architecture within the alpha-4,3 family, but with variations in side-chain solvent accessibility and orientation. Asp5, Pro6, and Arg7 in loop 1 are critical for blockade of both the alpha9alpha10 and the alpha7 subtypes. In loop 2, alpha-RgIA [Y10W] had activity near that of wild-type alpha-RgIA, with high potency for alpha9alpha10 and low potency for alpha7, and had a structure similar to that of wild type. By contrast, Arg9 in loop 2 is critical for specific binding to the alpha9alpha10 subtype, probably because it is larger and more solvent accessible than Ala9 in alpha-ImI. Our findings contribute to a better understanding of the molecular basis for antagonism of the alpha9alpha10 nAChR subtype, which is a target for the development of analgesics for the treatment of chronic neuropathic pain.


Current Biology | 2009

A Novel Conus Snail Polypeptide Causes Excitotoxicity by Blocking Desensitization of AMPA Receptors

Craig S. Walker; Stori Jensen; Michael Ellison; Jose A. Matta; Won Yong Lee; Julita S. Imperial; Nick Duclos; Penelope J. Brockie; David M. Madsen; John T. R. Isaac; Baldomero M. Olivera; Andres V. Maricq

BACKGROUND Ionotropic glutamate receptors (iGluRs) are glutamate-gated ion channels that mediate excitatory neurotransmission in the central nervous system. Based on both molecular and pharmacological criteria, iGluRs have been divided into two major classes, the non-NMDA class, which includes both AMPA and kainate subtypes of receptors, and the NMDA class. One evolutionarily conserved feature of iGluRs is their desensitization in the continued presence of glutamate. Thus, when in a desensitized state, iGluRs can be bound to glutamate, yet the channel remains closed. However, the relevance of desensitization to nervous system function has remained enigmatic. RESULTS Here, we report the identification and characterization of a novel polypeptide (con-ikot-ikot) from the venom of a predatory marine snail Conus striatus that specifically disrupts the desensitization of AMPA receptors (AMPARs). The stoichiometry of con-ikot-ikot appears reminiscent of the proposed subunit organization of AMPARs, i.e., a dimer of dimers, suggesting that it acts as a molecular four-legged clamp that holds the AMPAR channel open. Application of con-ikot-ikot to hippocampal slices caused a large and rapid increase in resting AMPAR-mediated current leading to neuronal death. CONCLUSIONS Our findings provide insight into the mechanisms that regulate receptor desensitization and demonstrate that in the arms race between prey and predators, evolution has selected for a toxin that blocks AMPAR desensitization, thus revealing the fundamental importance of desensitization for regulating neural function.


Biochemistry | 2006

α-RgIA: A novel conotoxin that specifically and potently blocks the α9α10 nAChR

Michael Ellison; Christian Haberlandt; María Eugenia Gómez-Casati; Maren Watkins; A. Belén Elgoyhen; J. Michael McIntosh; Baldomero M. Olivera


Journal of Biological Chemistry | 2003

α-conotoxins ImI and ImII: Similar α7 nicotinic receptor antagonists act at different sites

Michael Ellison; J. Michael McIntosh; Baldomero M. Olivera


Biochemistry | 2004

α-Conotoxins ImI and ImII Target Distinct Regions of the Human α7 Nicotinic Acetylcholine Receptor and Distinguish Human Nicotinic Receptor Subtypes†

Michael Ellison; Fan Gao; Hai Long Wang; Steven M. Sine; J. Michael McIntosh; Baldomero M. Olivera


Toxicon | 2004

αA-Conotoxin OIVA defines a new αA-conotoxin subfamily of nicotinic acetylcholine receptor inhibitors

Russell W. Teichert; Jean Rivier; John Dykert; Laura A. Cervini; Jozsef Gulyas; Grzegorz Bulaj; Michael Ellison; Baldomero M. Olivera


Toxicon | 2007

A novel alpha conotoxin (α-PIB) isolated from C. purpurascens is selective for skeletal muscle nicotinic acetylcholine receptors

Estuardo López-Vera; Richard B. Jacobsen; Michael Ellison; Baldomero M. Olivera; Russell W. Teichert


Chemical Record | 2007

α4/3 Conotoxins: phylogenetic distribution, functional properties, and structure–function insights

Michael Ellison; Baldomero M. Olivera


Archive | 2007

METHODS FOR TREATING PAIN AND SCREENING ANALGESIC COMPOUNDS

J. Michael McIntosh; Baldomero M. Olivera; Michael Ellison; Michelle Vincler

Collaboration


Dive into the Michael Ellison's collaboration.

Top Co-Authors

Avatar

Baldomero M. Olivera

Korea Research Institute of Bioscience and Biotechnology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge